• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与 GSK-3β 激酶结合的 BIS 样和其他配体:结合对接和 MM-PBSA 研究。

Binding of BIS like and other ligands with the GSK-3β kinase: a combined docking and MM-PBSA study.

机构信息

Molecular Biophysics Unit, Indian Institute of Science, Bangalore 560 012, India.

出版信息

J Mol Model. 2012 Feb;18(2):631-44. doi: 10.1007/s00894-011-1065-9. Epub 2011 May 11.

DOI:10.1007/s00894-011-1065-9
PMID:21559963
Abstract

Binding of several bisindolylmaleimide (BIS) like (BIS-3, BIS-8 and UCN1) and other ligands (H89, SB203580 and Y27632) with the glycogen synthase kinase-3 (GSK-3β) has been studied using combined docking, molecular dynamics and Poisson-Boltzmann surface area analysis approaches. The study generated novel binding modes of these ligands that can rationalize why some ligands inhibit GSK-3β while others do not. The relative binding free energies associated with these binding modes are in agreement with the corresponding measured specificities. This study further provides useful insight regarding possible existence of multiple conformations of some ligands like H89 and BIS-8. It is also found that binding modes of BIS-3, BIS-8 and UCN1 with GSK-3β and PDK1 kinases are similar. These new insights are expected to be useful for future rational design of novel, more potent GSK-3β-specific inhibitors as promising therapeutics.

摘要

使用组合对接、分子动力学和泊松-玻尔兹曼表面面积分析方法研究了几种双吲哚马来酰亚胺(BIS)类似物(BIS-3、BIS-8 和 UCN1)和其他配体(H89、SB203580 和 Y27632)与糖原合酶激酶-3(GSK-3β)的结合。该研究产生了这些配体的新结合模式,可以合理说明为什么有些配体抑制 GSK-3β,而有些则不抑制。这些结合模式相关的相对结合自由能与相应的实测特异性一致。这项研究进一步提供了有关某些配体(如 H89 和 BIS-8)可能存在多种构象的有用见解。还发现 BIS-3、BIS-8 和 UCN1 与 GSK-3β 和 PDK1 激酶的结合模式相似。这些新的见解有望为未来合理设计新型、更有效的 GSK-3β 特异性抑制剂作为有前途的治疗方法提供有用的信息。

相似文献

1
Binding of BIS like and other ligands with the GSK-3β kinase: a combined docking and MM-PBSA study.与 GSK-3β 激酶结合的 BIS 样和其他配体:结合对接和 MM-PBSA 研究。
J Mol Model. 2012 Feb;18(2):631-44. doi: 10.1007/s00894-011-1065-9. Epub 2011 May 11.
2
Structure-based approaches in the design of GSK-3 selective inhibitors.基于结构的GSK-3选择性抑制剂设计方法。
Curr Protein Pept Sci. 2007 Aug;8(4):352-64. doi: 10.2174/138920307781369409.
3
A flexible-protein molecular docking study of the binding of ruthenium complex compounds to PIM1, GSK-3β, and CDK2/Cyclin A protein kinases.钌配合物与 PIM1、GSK-3β 和 CDK2/Cyclin A 蛋白激酶结合的柔性蛋白分子对接研究。
J Mol Model. 2013 Jan;19(1):371-82. doi: 10.1007/s00894-012-1555-4. Epub 2012 Aug 29.
4
Molecular dynamics simulation studies of GSK-3β ATP competitive inhibitors: understanding the factors contributing to selectivity.糖原合成酶激酶-3β(GSK-3β)ATP竞争性抑制剂的分子动力学模拟研究:理解选择性的影响因素
J Biomol Struct Dyn. 2015;33(12):2578-93. doi: 10.1080/07391102.2015.1063457. Epub 2015 Nov 27.
5
Docking, molecular dynamics, binding energy-MM-PBSA studies of naphthofuran derivatives to identify potential dual inhibitors against BACE-1 and GSK-3β.萘并呋喃衍生物与 BACE-1 和 GSK-3β 双重抑制作用的对接、分子动力学、结合自由能-MM-PBSA 研究。
J Biomol Struct Dyn. 2019 Feb;37(2):275-290. doi: 10.1080/07391102.2018.1426043. Epub 2018 Jan 19.
6
Allosteric regulation of glycogen synthase kinase 3β: a theoretical study.别构调节糖原合酶激酶 3β:理论研究。
Biochemistry. 2010 Dec 28;49(51):10890-901. doi: 10.1021/bi100822q. Epub 2010 Dec 3.
7
Synthesis and discovery of macrocyclic polyoxygenated bis-7-azaindolylmaleimides as a novel series of potent and highly selective glycogen synthase kinase-3beta inhibitors.新型强效高选择性糖原合酶激酶-3β抑制剂——大环多氧代双-7-氮杂吲哚马来酰亚胺的合成与发现
J Med Chem. 2003 Sep 11;46(19):4021-31. doi: 10.1021/jm030115o.
8
From a natural product lead to the identification of potent and selective benzofuran-3-yl-(indol-3-yl)maleimides as glycogen synthase kinase 3beta inhibitors that suppress proliferation and survival of pancreatic cancer cells.从一种天然产物先导物出发,鉴定出强效且选择性的苯并呋喃-3-基-(吲哚-3-基)马来酰亚胺作为糖原合酶激酶3β抑制剂,其可抑制胰腺癌细胞的增殖和存活。
J Med Chem. 2009 Apr 9;52(7):1853-63. doi: 10.1021/jm801317h.
9
Discovery of potent and bioavailable GSK-3beta inhibitors.发现强效且有生物利用度的 GSK-3β 抑制剂。
Bioorg Med Chem Lett. 2010 Mar 1;20(5):1693-6. doi: 10.1016/j.bmcl.2010.01.038. Epub 2010 Jan 25.
10
Novel bis(indolyl)maleimide pyridinophanes that are potent, selective inhibitors of glycogen synthase kinase-3.新型双(吲哚基)马来酰亚胺吡啶环番,它们是糖原合酶激酶-3的强效、选择性抑制剂。
Bioorg Med Chem Lett. 2007 May 15;17(10):2863-8. doi: 10.1016/j.bmcl.2007.02.059. Epub 2007 Feb 25.

引用本文的文献

1
Estimation of relative binding free energy based on a free energy variational principle for the FKBP-ligand system.基于自由能变分原理估算 FKBP-配体系统的相对结合自由能。
J Comput Aided Mol Des. 2013 Jun;27(6):479-90. doi: 10.1007/s10822-013-9657-3. Epub 2013 Jun 11.

本文引用的文献

1
Comparison of computational methods to model DNA minor groove binders.比较用于模拟 DNA 小沟结合物的计算方法。
J Chem Inf Model. 2011 Mar 28;51(3):558-71. doi: 10.1021/ci100474n. Epub 2011 Mar 4.
2
Structural features underlying selective inhibition of GSK3β by dibromocantharelline: implications for rational drug design.二溴坎替来林选择性抑制 GSK3β 的结构基础:对合理药物设计的启示。
Chem Biol Drug Des. 2011 Mar;77(3):199-205. doi: 10.1111/j.1747-0285.2010.01069.x. Epub 2011 Jan 19.
3
Discovery of novel GSK-3β inhibitors with potent in vitro and in vivo activities and excellent brain permeability using combined ligand- and structure-based virtual screening.
采用基于配体和结构的虚拟筛选相结合的方法,发现了具有较强体外和体内活性以及优异脑渗透性的新型 GSK-3β 抑制剂。
J Med Chem. 2010 Dec 23;53(24):8534-45. doi: 10.1021/jm100941j. Epub 2010 Nov 17.
4
MM-PBSA Captures Key Role of Intercalating Water Molecules at a Protein-Protein Interface.MM-PBSA揭示了嵌入水分子在蛋白质-蛋白质界面的关键作用。
J Chem Theory Comput. 2009 Feb 10;5(2):422-429. doi: 10.1021/ct8003707. Epub 2009 Jan 22.
5
Binding of small-molecule ligands to proteins: "what you see" is not always "what you get".小分子配体与蛋白质的结合:“所见”未必“所得”。
Structure. 2009 Apr 15;17(4):489-98. doi: 10.1016/j.str.2009.02.010.
6
The role of glycogen synthase kinase 3 in the early stages of Alzheimers' disease.糖原合酶激酶3在阿尔茨海默病早期阶段的作用。
FEBS Lett. 2008 Nov 26;582(28):3848-54. doi: 10.1016/j.febslet.2008.10.026. Epub 2008 Oct 26.
7
Knowledge based prediction of ligand binding modes and rational inhibitor design for kinase drug discovery.基于知识的配体结合模式预测与激酶药物发现的合理抑制剂设计。
J Med Chem. 2008 Sep 11;51(17):5149-71. doi: 10.1021/jm800475y. Epub 2008 Aug 19.
8
Investigation of MM-PBSA rescoring of docking poses.对接姿势的MM-PBSA重新评分研究。
J Chem Inf Model. 2008 May;48(5):1081-91. doi: 10.1021/ci700470c. Epub 2008 May 9.
9
Combining docking, molecular dynamics and the linear interaction energy method to predict binding modes and affinities for non-nucleoside inhibitors to HIV-1 reverse transcriptase.结合对接、分子动力学和线性相互作用能方法预测非核苷类抑制剂与HIV-1逆转录酶的结合模式和亲和力。
J Med Chem. 2008 May 8;51(9):2648-56. doi: 10.1021/jm7012198. Epub 2008 Apr 12.
10
Dynamics in the p38alpha MAP kinase-SB203580 complex observed by liquid-state NMR spectroscopy.通过液态核磁共振光谱法观察到的p38α丝裂原活化蛋白激酶-SB203580复合物中的动力学
Angew Chem Int Ed Engl. 2008;47(19):3548-51. doi: 10.1002/anie.200705614.